657 Interleukin-6 receptor blockade for management of immune checkpoint inhibitor related adverse events in patients with melanoma

• Adi Diab,
• Faisal Fa’ak,
• Noha Abdel-Wahab,
• Jean Tayar,
• Huifang Lu,
• Maria Suarez-Almazor,
• Stephen Gruschkus,
• Daniel Johnson,
• Chantal Saberian,
• May Daher,
• Sang Kim,
• Maryam Buni,
• Kaysia Ludford

Affiliations

Adi Diab

2The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Faisal Fa’ak

2Piedmont Athens Regional Medical Center, Atehns, GA, USA

Noha Abdel-Wahab

4MD Anderson Cancer Center, Bellaire, TX, USA

Jean Tayar

3MD Anderson Cnacer Center, Houston, TX, USA

Huifang Lu

4MD Anderson Cancer Center, Bellaire, TX, USA

Maria Suarez-Almazor

4MD Anderson Cancer Center, Bellaire, TX, USA

Stephen Gruschkus

4MD Anderson Cancer Center, Bellaire, TX, USA

Daniel Johnson

5Louisiana State Univeristy, New Orleans, LA, USA

Chantal Saberian

1The University of Texas MD Anderson Cancer Center, Bellaire, TX, USA

May Daher

1The University of Texas MDACC, Houston, USA

Sang Kim

4MD Anderson Cancer Center, Bellaire, TX, USA

Maryam Buni

4MD Anderson Cancer Center, Bellaire, TX, USA

Kaysia Ludford

4MD Anderson Cancer Center, Bellaire, TX, USA